AR117605A1 - PYRAZINE DERIVATIVES FUSED AS A2A / A2B INHIBITORS - Google Patents
PYRAZINE DERIVATIVES FUSED AS A2A / A2B INHIBITORSInfo
- Publication number
- AR117605A1 AR117605A1 ARP190101875A ARP190101875A AR117605A1 AR 117605 A1 AR117605 A1 AR 117605A1 AR P190101875 A ARP190101875 A AR P190101875A AR P190101875 A ARP190101875 A AR P190101875A AR 117605 A1 AR117605 A1 AR 117605A1
- Authority
- AR
- Argentina
- Prior art keywords
- inhibitors
- pyrazine derivatives
- diseases
- derivatives fused
- activity
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente solicitud hace referencia a compuestos de fórmula (1), o sales farmacéuticamente aceptable de este, el cual modula la actividad de receptores de adenosina, tales como los subtipos de receptores A2A y A2B, y son útiles para el tratamiento de enfermedades relacionadas a la actividad de los receptores de adenosina, lo que incluye, por ejemplo, cáncer, enfermedades inflamatorias, enfermedades cardiovasculares y enfermedades neurodegenerativas.The present application refers to compounds of formula (1), or pharmaceutically acceptable salts thereof, which modulate the activity of adenosine receptors, such as the A2A and A2B receptor subtypes, and are useful for the treatment of diseases related to the activity of adenosine receptors, including, for example, cancer, inflammatory diseases, cardiovascular diseases, and neurodegenerative diseases.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862694138P | 2018-07-05 | 2018-07-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR117605A1 true AR117605A1 (en) | 2021-08-18 |
Family
ID=77568246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190101875A AR117605A1 (en) | 2018-07-05 | 2019-07-03 | PYRAZINE DERIVATIVES FUSED AS A2A / A2B INHIBITORS |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR117605A1 (en) |
-
2019
- 2019-07-03 AR ARP190101875A patent/AR117605A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP21007838A (en) | PYRAZINE DERIVATIVES FUSED AS A2A / A2B INHIBITORS | |
| CL2022003185A1 (en) | Midazopyrimidines and triazolopyrimidines as a2a/a2b inhibitors ((sol. div. 202002198) | |
| CL2021001984A1 (en) | Pyrazolopyridines and triazolopyridines as a2a/a2b inhibitors. | |
| CO2022003457A2 (en) | Triazolopyrimidines as a2a/a2b inhibitors | |
| ECSP21008112A (en) | PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS | |
| UY37574A (en) | AZOLOPIRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS | |
| UY37725A (en) | QUINAZOLINE-PYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER-RELATED DISORDERS | |
| UY37124A (en) | NEW COMPOUNDS OF 6,7-DIHIDRO-5H-BENZO [7] REPLACED CANCELLATION, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES OF THE SAME | |
| CR20150633A (en) | BIPIRAZOL DERIVATIVES AS JAK INHIBITORS | |
| AR094964A1 (en) | USE OF PIRAZOLOPIRIMIDINE DERIVATIVES FOR THE TREATMENT OF PHOSFOINOSITIDE-RELATED 3-CINASE D (PI3Kd) | |
| UY35898A (en) | ? SYK INHIBITING COMPOUNDS AND COMPOSITIONS THAT UNDERSTAND THEM ?. | |
| MX2020012376A (en) | Fused pyrimidine derivatives as a2a / a2b inhibitors. | |
| ECSP20061378A (en) | DIOLIC AMINOPYRAZINE COMPOUNDS AS PI3K-gamma INHIBITORS | |
| UY36875A (en) | BROMODOMINIUM INHIBITING COMPOSITIONS FOR THE TREATMENT OF VARIOUS DISEASES | |
| CL2020001047A1 (en) | Fused imidazole derivatives substituted by tertiary hydroxy groups as pi3k-gamma inhibitors. | |
| CL2019000662A1 (en) | Dopamine-b-hydroxylase inhibitors. | |
| AR117605A1 (en) | PYRAZINE DERIVATIVES FUSED AS A2A / A2B INHIBITORS | |
| ECSP18056196A (en) | DERIVATIVES OF INDANO | |
| CL2017002605A1 (en) | Indole derivatives | |
| EA202190204A1 (en) | CONDENSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS | |
| EA202092016A1 (en) | IMIDAZOPYRIMIDINES AND TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS |